Dimensional Fund Advisors’s Tonix Pharmaceuticals TNXP Stock Holding History

Dimensional Fund Advisors’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$185K	Buy	+14,521	New	+$187K	﹤0.01%	3084
2022 Q3	–	Sell	-1	Closed	-$20K	–	3523
2022 Q2	$20K	Buy	+1	New	+$73.8K	﹤0.01%	3444
2019 Q3	–	Hold	0	–	-$14K	–	3435
2019 Q2	–	Hold	0	–	–	–	3461
2019 Q1	–	Hold	0	–	–	–	3419
2018 Q4	–	Hold	0	–	-$34K	–	3460
2018 Q3	–	Hold	0	–	–	–	3403
2018 Q2	–	Hold	0	–	–	–	3222
2018 Q1	–	Hold	0	–	–	–	3261
2017 Q4	–	Hold	0	–	–	–	3242
2017 Q3	–	Hold	0	–	–	–	3286
2017 Q2	–	Hold	0	–	–	–	3311
2017 Q1	–	Hold	0	–	–	–	3300
2016 Q3	–	Hold	0	–	-$169K	–	3283
2016 Q2	–	Hold	0	–	–	–	3199
2016 Q1	–	Hold	0	–	–	–	3177
2015 Q4	–	Hold	0	–	–	–	3048
2015 Q3	–	Hold	0	–	–	–	3132
2015 Q1	–	Hold	0	–	-$18K	–	3393
2014 Q4	–	Hold	0	–	–	–	3427

Other funds holding TNXP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JHC

Jones Hill Capital New York $470M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ishara Investments Los Angeles, California $136M AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Dimensional Fund Advisors's TNXP Position: Q2 2026 in Review

Dimensional Fund Advisors opened a new position in Tonix Pharmaceuticals (TNXP) in Q2 2026: 14,521 shares worth $185K. The stake represents ﹤0.01% of the portfolio and ranks #3084 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in TNXP as recently as Q2 2022.

Dimensional Fund Advisors first reported a position in TNXP in Q2 2022 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

Dimensional Fund Advisors held 14,521 shares of Tonix Pharmaceuticals worth $185K as of Q2 2026.
Tonix Pharmaceuticals was a new Dimensional Fund Advisors position in Q2 2026.
Tonix Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3084 holding.
Dimensional Fund Advisors first reported a position in Tonix Pharmaceuticals in Q2 2022 and has held it in 2 quarters since.
103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.